Our Smad4-mutant tumor model lacks PD-L1 expression in vitro, and although the in vivo tumors were PD-L1-positive, the PD-L1 expression was primarily on infiltrating immune cells rather than on the tumor cells themselves. The gene discussed is SMAD4; the disease is neoplasm.